Pfizer begins testing use of pneumococcal vaccine along with COVID-19 booster shot
(Reuters) – Pfizer Inc said on Monday it began testing fully vaccinated adults over 65 in a new study that uses the company's 20-valent pneumococcal conjugate vaccine (20vPnC) candidate with a third dose of the Pfizer-BioNTech COVID-19 shot. The aim of the study is to understand if the combination of the vaccines is safe, and the immune response after adding […]
Read more